Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Opus Genetics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 27 | 36 | +9 |
| Shares | 912.3K | 1.07M | +156.3K (+17.1%) |
| Value | $5.27M | $5.61M | +$340.9K (+6.5%) |
New holders (14)
Institutions that held Opus Genetics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 329,131 | $1.74M | 0.01% |
| Susquehanna International Group, LLP | 59,172 | $312.0K | 0.00% |
| State Street Corp | 54,573 | $288.0K | 0.00% |
| Goldman Sachs Group Inc | 37,315 | $197.0K | 0.00% |
| Jane Street Group, LLC | 24,984 | $132.0K | 0.00% |
| Occudo Quantitative Strategies LP | 23,445 | $124.0K | 0.02% |
| Group One Trading, L.P. | 19,977 | $105.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 16,441 | $87.0K | 0.00% |
| Man Group plc | 14,900 | $79.0K | 0.00% |
| Citadel Advisors LLC | 14,257 | $75.0K | 0.00% |
| Cornerstone Capital, Inc. | 11,357 | $60.0K | 0.01% |
| Cutler Group LP | 7,900 | $41.0K | 0.00% |
| Deutsche Bank AG | 1,400 | $7.00K | 0.00% |
| Salem Investment Counselors Inc | 10 | $0 | 0.00% |
Sold out (5)
Institutions that held Opus Genetics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Altium Capital Management LP | 397,036 | $2.31M |
| Pura Vida Investments, LLC | 57,536 | $334.0K |
| Millennium Management LLC | 12,692 | $74.0K |
| Acadian Asset Management LLC | 2,174 | $13.0K |
| Steward Partners Investment Advisory, LLC | 15 | $87 |